Latest Breaking News On - Mario saporta - Page 1 : comparemela.com

Cultivating Passion For Medical Research

Cultivating Passion For Medical Research
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of miamiFlorida international universityMiller schoolEthan tieuMario saportaErika liberusMiller school of medicineUs department of defenseOffice of academic enhancementHurricanes in mahoney residential collegeBookert washington high schoolGoldwater scholarFlorida internationalMiami projectCure paralysis

Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society

Applied Therapeutics to Present Data on AT-007 (Govorestat) Treatment in SORD Deficiency at the 2023 Annual Meeting of the Peripheral Nerve Society
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Juan youngVera fridmanStephan zuchnerAmanda lobatoMario saportaDavid hermannLemuel rivera fuentesChristopher yanickMichael hassmanKatherina walzYi zhuRadim mazanecSteven schererPavel seemanShoshana shendelmanNatalie ortiz vega

Applied Therapeutics (APLT) Receives Orphan Medicinal Product Designation in Europe for Govorestat

Applied Therapeutics (APLT) Receives Orphan Medicinal Product Designation in Europe for Govorestat
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Maeve conneightonAmandag lobatoAdrianap rebeloYi zhuRiccardo perfettiSheyum syedChristopher yanickShoshana shendelmanMario saportaNatalie ortiz vegaXianzun taoTherapeutics incEuropean medicines agencyExchange commissionWall streetSorbitol dehydrogenase

Govorestat (AT-007) Receives Orphan Medicinal Product Designation from the EMA for Treatment of SORD Deficiency

EMA Orphan Designation reflects high unmet need in SORD Deficiency and benefit of govorestat treatment in reducing toxic sorbitol levelsNew data published in Journal of Clinical Investigation further. | May 25, 2023

Shoshana shendelmanSheyum syedChristopher yanickMario saportaNatalie ortiz vegaXianzun taoAmandag lobatoMaeve conneightonYi zhuRiccardo perfettiAdrianap rebeloTherapeutics incEuropean medicines agencyExchange commissionClinical investigationSorbitol dehydrogenase

Pharnext Confirms Details for 2021 Hybrid Research & Development Day

Event to be held in person in New York, or virtually via a simultaneous live webcast, on Wednesday October 27, 2021 at 8:30 am ET/ 2:30 pm CETPARIS, FRANCE / ACCESSWIRE / October 21, 2021 / Pharnext SA

Baden wübergNew yorkUnited statesFrance generalSukaina virjiXavier paoliGhislaine gasparettoFlorianp thomasAdrian hepnerMary jane elliottMario saportaAlexandra harrisonAllison mooreDepartment of neurologyEuronext growth stock exchangeExcellence at miller school of medicine